XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Interim Condensed Consolidated Statements of Cash Flows - CAD ($)
3 Months Ended 12 Months Ended
May 31, 2022
May 31, 2021
Feb. 28, 2022
Feb. 28, 2021
Operating activities        
Net loss $ (3,166,214) $ (634,598) $ (4,372,019) $ (2,667,423)
Non-cash items:        
Depreciation and amortization 412,655 16,657 841,766 0
Interest accretion on lease liability 61,575 6,430 202,844 0
Realized gain on sale of marketable securities     (10,107) 0
Gain on share for debt settlement     15,538 0
Stock based compensation 489,089 19,087 1,196,361 237,714
Change in fair value of contingent consideration 459,693 0 (5,853,701) 0
Provision for impairment     5,520,522 0
Forgiveness of long-term debt, net     918,361 0
Change in fair value of SDP earn-out consideration 2,451,600 0    
Change in fair value of marketable securities 0 (12,045) (6,881) 812
Impairment of other investments     0 183,466
Changes in operating assets and liabilities:        
Accounts receivable (110,662) (193,564) (2,065,879) 0
Net repayment of credit receivables     0 394,091
Prepaid expenses and other receivables (42,082) (458,457) 82,104 (2,440)
Inventories (779,655) 115,076 248,445 0
Accounts payable and accrued liabilities (523,938) 498,097 1,516,369 878,606
Other liabilities 300,968 0 12,759 0
Deferred tax liability (58,980) 0 (113,639) 0
Net cash used in operating activities (505,951) (643,317) (3,703,879) (975,174)
Investing activities        
Cash received on acquisition of SDP 0 255 255 0
Cash received on acquisition of Mio-Guard 3,363 0    
Acquisition of property and equipment (39,212) 0 (55,259) 0
Cash received on acquisition of Simbex, LLC     632,697 0
Proceeds on sale of marketable securities     496,526 445,101
Purchase of marketable securities     0 (186,765)
Purchase of other investments     0 (183,466)
Acquisition of Simbex, LLC     (5,691,759) 0
Net cash (used in) provided by investing activities (35,849) 255 (4,617,540) 74,870
Financing activities        
Repayment of long-term debt, net (42,541) (211,436) (2,263,306) 0
Repayment of line of credit, net (239,084) (186,623)    
Issuance costs 0 (124,884) (660,052) 0
Proceeds from exercise of stock options 5,329 176,000 376,892 5,348
Proceeds from exercise of broker warrants 215,953 0    
Lease payments (132,402) 0 (269,954) 0
Proceeds from term-loan, net     939,696 0
Proceeds from refinancing of line of credit 0   1,549,929 0
Proceeds from issuance of shares     4,261,950 0
Proceeds from subscription receipts     0 5,425,374
Net cash provided by financing activities (192,745) (346,943) 3,935,155 5,430,722
Effect of foreign exchange rates on cash (445,731) (255,216) (62,778) (373,698)
Decrease in cash and cash equivalents and restricted cash (734,545) (990,005) (4,386,264) 4,530,418
Cash and cash equivalents and restricted cash, opening 8,057,100 12,506,142 12,506,142 8,349,422
Cash and cash equivalents and restricted cash, closing 6,876,824 11,260,921 8,057,100 12,506,142
Supplementary information:        
Interest paid 70,274 16,207 388,065  
Income taxes paid 0 0 12,022 0
Common stock issued for debt 0 94,999 94,999 0
Restricted cash included in the closing balance above $ 0 $ 889,473 $ 0 $ 5,425,374